25
MODIFIED BACTERIOPHAGE LAMBDA PROCAPSIDS FOR USE AS A DRUG DELIVERY PLATFORM. Presentation by: Nicole Rowley and Kyle Koshland

Viral Nanoparticle Research Conference

Embed Size (px)

Citation preview

Page 1: Viral Nanoparticle Research Conference

MODIFIED BACTERIOPHAGE

LAMBDA PROCAPSIDS FOR USE AS A DRUG

DELIVERY PLATFORM.Presentation by:Nicole Rowley and Kyle Koshland

Page 2: Viral Nanoparticle Research Conference

◎ Advantages of using viruses

◎ What are Procapsids?

◎ Optimization of Procapsid Production

◎ Procapsid Modification

◎ Future Directions

Presentation Overview

Page 3: Viral Nanoparticle Research Conference

Advantages of Viruses◎ Variety of shapes and sizes in

nanometer size range

http://epidemiologiamolecular.com/wp-content/uploads/2011/08/clip_image0064.jpg

◎ Non-toxic◎ Inexpensive to produce◎ Amino acid residues can be

chemically and genetically modified

Page 4: Viral Nanoparticle Research Conference

◎ Procapsid without DNA or tail◎ Bacteriophage of E. coli

What Are Lambda Procapsids?

http://pdbj.org/emnavi/emnavi_detail.php?id=1507

Page 5: Viral Nanoparticle Research Conference

2 Main Goals:

1. Procapsid Prep

2. Procapsid Modification

Page 6: Viral Nanoparticle Research Conference

2 Main Goals:

1. Procapsid Prep

2. Procapsid ModificationFor drug

packaging

For quantification of modification

sites

Page 7: Viral Nanoparticle Research Conference

2 Main Goals:

1. Procapsid Prep

2. Procapsid Modification

Page 8: Viral Nanoparticle Research Conference

And the difficulties of finding a procedure that works!

1.Lambda Procapsid Prep

http://pdbj.org/emnavi/emnavi_detail.php?id=1507

Page 9: Viral Nanoparticle Research Conference

Plasmid TransformationDNA GpE/GpD Plasmid

Origin of Replication

Ampicillin Resistance

GpE/GpD

T7 Promotor

Operator

http://vignette2.wikia.nocookie.net/mmg-233-2013-genetics-genomics/images/e/e2/Transformation.png/revision/latest?cb=20131002205536

Heat Shock

LacI

Page 10: Viral Nanoparticle Research Conference

Procapsid Formation

http://viralzone.expasy.org/all_by_protein/3945.html

◎ Scaffolding proteins assist

○ Bonds break up completion

○ Not occurring in λ procapsid◎ Assemblies by Brownian Motion

Page 11: Viral Nanoparticle Research Conference

Ladd

er

+Con

trol

Resea

rch P

rep

SDS Gel Shows No ProductkDa

260

160

11080

60 50

40

3020

Capsid Protein

Page 12: Viral Nanoparticle Research Conference

Confirmation of Product

Ladd

er

+ Con

trol

Resea

rch P

rep

Capsid Protein

kDa260

160

110 80

60

50 40

30

20 1510

Ladder

Research Prep

kDa260

160

110

80

60

5040

30

20

Capsid Protein

Page 13: Viral Nanoparticle Research Conference

Intact Procapsid Confirmed

Intact

Denatured

Page 14: Viral Nanoparticle Research Conference

2 Main Goals:

1. Procapsid Prep

2. Procapsid Modification

Page 15: Viral Nanoparticle Research Conference

2 Main Goals:

1. Procapsid Prep

2. Procapsid Modification

Page 16: Viral Nanoparticle Research Conference

2.Procapsid Shell Modifications

https://www.carthage.edu/live/files/723-heidifenskemaxwell-maxhurickposterpdf

Page 17: Viral Nanoparticle Research Conference

Maleimide Modification

http://www.drugtargetreview.com/4442/content-type/industry-news/genticel-announces-positive-preclinical-proof-of-concept-results-for-its-multivalent-hpv-therapeutic-vaccine-gtl002/

R = Cy5

Intact

Denatured

Dye

Intact

Page 18: Viral Nanoparticle Research Conference

NHS Ester Modification

http://www.drugtargetreview.com/4442/content-type/industry-news/genticel-announces-positive-preclinical-proof-of-concept-results-for-its-multivalent-hpv-therapeutic-vaccine-gtl002/

R = Cy5

Intact Intact

Page 19: Viral Nanoparticle Research Conference

Quantification labels◎ Used Beer’s Law

○ Extinction coefficient◎ Average successful labeled amino acids

○ Lysines:

◉ 274 Cy5/Intact Procapsid

○ Cysteines:

◉ 208 Cy5/Intact Procapsid

http://www.pharmaceuticalonline.com/doc/lambert-beer-law-0001

Page 20: Viral Nanoparticle Research Conference

Quantification stability◎ Stability after conjugation

○ Lysine chemistry:

◉ 92.75% Intact○ Cysteine chemistry:

◉ 50.67% Intact◎ Calculated from area under curve

○ Ratio of intact to broken procapsids

Page 21: Viral Nanoparticle Research Conference

Further Experimentatio

n◎ Procapsid modifications

○ Attach linker and targeting protein

◎ Mouse studies

○ Inflammation in lupus mouse model

○ Blood-Brain barrier

Page 22: Viral Nanoparticle Research Conference

Any Questions?

Page 23: Viral Nanoparticle Research Conference

Thank You

Page 24: Viral Nanoparticle Research Conference
Page 25: Viral Nanoparticle Research Conference

FPLC: Procapsid (Denatured)

FPLC Results